First Tracks Biotherapeutics, Inc. (TRAX)
31.22
-0.17
(-0.54%)
USD |
NASDAQ |
Oct 07, 11:20
First Tracks Biotherapeutics Net Income (Quarterly) : -33.37M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -33.37M |
| March 31, 2026 | -50.48M |
| Date | Value |
|---|---|
| June 30, 2025 | -42.44M |
| March 31, 2025 | -47.20M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Forte Biosciences, Inc. | -23.33M |
| AnaptysBio, Inc. | 229.24M |
| Immunovant, Inc. | -153.22M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Agenus, Inc. | -0.567M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 33.37M |
| EPS Diluted (Quarterly) | -0.943 |
| Enterprise Value | 947.23M |
| Earnings Yield | -15.83% |
| Normalized Earnings Yield | -15.83 |